Zero-Covid? NATO's China Challenge, Quarter-End Volume, Yields, Trading Chevron

There was a time when Covid vaccine news was headline material. Not now, though, and this news could matter.

Get the Facts, Not the Hype, Then Trade

Rather than waste time trying to predict when, or if, a recession is on the way, why not simply buy shares that appear quite undervalued? Here are two to start with.

What's the 'Pain Trade' Now?

Is it more rallying to suck more people in? Or is it a rollover that will spit out those 'Sentiment Tourists'? Let's take a look.

Don't Shout 'V' for Victory, Yet

Even after last week's move higher and Monday's narrow range of movement, we can say it's going to be difficult to produce a 'V'-shaped setup like we had at the pandemic low in 2020.

Let's See If Vertex Pharmaceuticals Can Push Higher on the Charts

Here's what traders should do.

Kass: Why Markets Could Make a Yankees-Like Comeback

I remain uncharacteristically bullish. Here's why.

Here's How to Treat Bristol-Myers Squibb's Charts

BMY is breaking out to a new high.

If You Buy Now in This Bear-Bull Battle, You May Be Paying Later

You really want to snag a bargain -- and bank a win -- right now. Here's a better strategy.

Should You Buy Micron Technology Ahead of Earnings?

The chipmaker reports its latest quarterly results this week.